Epizyme Inc. (EPZM) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Mon March 15th, 2021

- 11:39
  AnalysisEpizyme (EPZM) Presents At The Next EPIsode: Rewriting Oncology Treatment with Epigenetics - SlideshowSeeking Alpha
- 11:38
  AnalysisEpizyme (EPZM) Presents At Barclays Global Healthcare Conference - SlideshowSeeking Alpha

Thu February 25th, 2021

- 17:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  RatingEpizyme downgraded to equal weight at Morgan StanleyMarketWatch

Wed February 24th, 2021

- 17:17
  AnalysisEpizyme's (EPZM) Q4 Loss Wider than Expected, Sales BeatZacks
- 01:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisEpizyme Inc (EPZM) Q4 2020 Earnings Call TranscriptThe Motley Fool

Tue February 23rd, 2021

- 17:13
  EarningsAnalysisEpizyme's (EPZM) CEO Rob Bazemore on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha
- 14:34
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisEpizyme, Inc. 2020 Q4 - Results - Earnings Call PresentationSeeking Alpha
- 12:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisEpizyme (EPZM) Reports Q4 Loss, Tops Revenue EstimatesZacks + 3 more

Sun February 14th, 2021

- 13:10
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisGuideReassessing EpizymeSeeking Alpha

Sun December 6th, 2020

- 16:30
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisEpizyme (EPZM) Down 3.4% Since Last Earnings Report: Can It Rebound?Zacks

Mon November 9th, 2020

- 15:16
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisEpizyme's (EPZM) Q3 Loss Narrower Than Expected, Sales MissZacks

Sat November 7th, 2020

- 00:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisEpizyme Inc (EPZM) Q3 2020 Earnings Call TranscriptThe Motley Fool

Fri November 6th, 2020

- 19:46
  EarningsAnalysisEpizyme, Inc. (EPZM) CEO Robert Bazemore on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha
- 12:45
  AnalysisEpizyme (EPZM) Reports Q3 Loss, Misses Revenue EstimatesZacks + 2 more

Wed October 28th, 2020

- 16:33
  EarningsAnalysisEpizyme (EPZM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks

Mon October 5th, 2020

- 13:43
  RumorsEpizyme (EPZM) Highlighted on Sector DealStreetInsider

Wed September 23rd, 2020

- 19:01
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  RumorsEpizyme Inc. (EPZM), Epizyme Inc (EPZM) on watch amid unconfirmed chatterStocktwits

Thu September 3rd, 2020

- 15:31
  EarningsAnalysisWhy Is Epizyme (EPZM) Up 0.6% Since Last Earnings Report?Zacks

Wed August 5th, 2020

- 15:29
  EarningsAnalysisEpizyme's (EPZM) Q2 Earnings and Revenues Miss EstimatesZacks

Tue August 4th, 2020

Wed July 1st, 2020

- 05:37
  AnalysisEpizyme A Buy For Tazverik And Epigenetic PlatformSeeking Alpha

Mon June 29th, 2020

- 06:03
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisInsider Weekends: Harold Hamm Buys More Of Continental ResourcesSeeking Alpha

Sun June 21st, 2020

- 07:11
  AnalysisAptinyx PTSD Trial And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha

Fri June 19th, 2020

- 13:41
  AnalysisAre Options Traders Betting on a Big Move in Epizyme (EPZM) Stock?Zacks

Thu June 18th, 2020

- 20:57
  AnalysisEpizyme's Tazverik Wins FDA Approval to Treat Follicular LymphomaThe Motley Fool + 1 more
- 12:34
  DigestThe Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA DecisionsBenzinga

Sun June 14th, 2020

- 14:20
  The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And UltragenyxBenzinga

Sat June 13th, 2020

- 12:55
  AnalysisStocks To Watch: Spotlight On EVs, Shipping And HertzSeeking Alpha

Wed June 3rd, 2020

- 15:30
  EarningsAnalysisEpizyme (EPZM) Down 4.4% Since Last Earnings Report: Can It Rebound?Zacks

Wed May 27th, 2020

- 14:08
  Epizyme, Inc. Is Doing Everything Right But Its Shares Appear Fairly PricedSeeking Alpha

SPY$395.63-3.8%

QQQ$315.85-6.1%

DOW$64.14-0.16%

APHA$17.4523%

TLRY$22.1227%

SPY$395.63-3.8%

QQQ$315.85-6.1%

DOW$64.14-0.16%

APHA$17.4523%

TLRY$22.1227%

About Developer Contact